WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST)

CUSIP: 955306105

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
71,941,794
Total 13F shares
68,617,905
Share change
+511,358
Total reported value
$25,750,554,481
Put/Call ratio
102%
Price per share
$375.21
Number of holders
753
Value change
+$188,033,862
Number of buys
312
Number of sells
350

Quarterly Holders Quick Answers

What is CUSIP 955306105?
CUSIP 955306105 identifies WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2023

As of 30 Sep 2023, WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) was held by 753 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,617,905 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Bank of New York Mellon Corp, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, APG Asset Management N.V., FRANKLIN RESOURCES INC, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, and Artisan Partners Limited Partnership. This page lists 754 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.